Impact of obesity in favorable-risk AML patients receiving intensive chemotherapy.

Tavitian, Suzanne

Impact of obesity in favorable-risk AML patients receiving intensive chemotherapy. [electronic resource] - American journal of hematology Feb 2016 - 193-8 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1096-8652

10.1002/ajh.24228 doi


Aged
Antineoplastic Combined Chemotherapy Protocols--administration & dosage
Body Mass Index
Body Surface Area
Disease-Free Survival
Dose-Response Relationship, Drug
Drug Administration Schedule
Female
Humans
Induction Chemotherapy
Leukemia, Myeloid, Acute--complications
Male
Middle Aged
Multivariate Analysis
Obesity--complications
Retrospective Studies
Risk
Treatment Outcome